These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17484719)

  • 41. Adverse-drug-event data provided by pharmaceutical companies.
    Cudny ME; Graham AS
    Am J Health Syst Pharm; 2008 Jun; 65(11):1071-5. PubMed ID: 18499882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical pharmacists save thousands of lives: big decrease in dose-related adverse effects.
    Powell JR
    Pharmacotherapy; 2004 Mar; 24(3):422-5. PubMed ID: 15040659
    [No Abstract]   [Full Text] [Related]  

  • 44. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 45. Misleading information for consumers.
    Torpy D
    Med J Aust; 2007 May; 186(9):483-4. PubMed ID: 17484713
    [No Abstract]   [Full Text] [Related]  

  • 46. [Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
    Péré JC; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
    Therapie; 1987; 42(4):351-8. PubMed ID: 3686468
    [No Abstract]   [Full Text] [Related]  

  • 47. Delphi survey of international pharmacology experts: an attempt to derive international recommendations for use of medicine in breastfeeding women.
    Amir LH; Ryan K; Barnett C
    Breastfeed Med; 2015 Apr; 10(3):168-74. PubMed ID: 25775374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safe use of acetaminophen.
    Barton KN
    CMAJ; 2003 May; 168(11):1390. PubMed ID: 12771057
    [No Abstract]   [Full Text] [Related]  

  • 49. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium in drug treatments: Information about sodium in medicines is available.
    McEntee JE
    BMJ; 2008 Jul; 337(7660):a599. PubMed ID: 18595908
    [No Abstract]   [Full Text] [Related]  

  • 51. Prescribing information in 26 countries: a comparative study.
    Reggi V; Balocco-Mattavelli R; Bonati M; Breton I; Figueras A; Jambert E; Kopp C; Montane E; Rägo L; Rocchi F;
    Eur J Clin Pharmacol; 2003 Aug; 59(4):263-70. PubMed ID: 12759794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contraindication labelling changes in the United States and Germany.
    Garbe E; Andersohn F
    Eur J Clin Pharmacol; 2007 Jan; 63(1):87-93. PubMed ID: 17124576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
    Marwick C
    JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
    [No Abstract]   [Full Text] [Related]  

  • 54. Medication safety: opening up the black box.
    Mintzes B
    BMJ Qual Saf; 2013 Sep; 22(9):702-4. PubMed ID: 23832923
    [No Abstract]   [Full Text] [Related]  

  • 55. [Drug package inserts--varying information for the same medicines].
    Storflor JG; Pettersen LC; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2013 May; 133(9):955-9. PubMed ID: 23652143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety warnings and first aid instructions on consumer and pharmaceutical products in Nigeria: has there been an improvement?
    Nonyelum SC; Nkem N; Ifeyinwa CN; Orisakwe OE
    J Pak Med Assoc; 2010 Oct; 60(10):801-4. PubMed ID: 21381605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in product information of biopharmaceuticals in the EU and the USA: implications for product development.
    Nieminen O; Kurki P; Nordström K
    Eur J Pharm Biopharm; 2005 Aug; 60(3):319-26. PubMed ID: 15996576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual regulatory pharmaceutical labeling schemes; the role of the Federal Preemption Doctrine.
    Fern FH; Bartell L
    Health Matrix; 1987; 5(3):17-23. PubMed ID: 10285381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Package leaflets of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study.
    Pires C; Vigário M; Cavaco A
    Sao Paulo Med J; 2015; 133(2):91-100. PubMed ID: 25337666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Over-the-counter product line extensions: have we reached the limit yet?
    Sansgiry SS
    J Am Geriatr Soc; 2004 Jul; 52(7):1223-4. PubMed ID: 15209675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.